RBC Europe’s Vicarious Surgical RBOT Stock Holding History

RBC Europe’s Portfolio RBOT Stock Details RBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7	Closed	-$2.99K	–	1026
2021 Q3	$2.99K	Buy	+7	New	+$2.22K	﹤0.01%	1094

Other funds holding RBOT

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HVCM

Hel Ved Capital Management Central, Hong Kong $844M AUM 191.74% 1-Year Est. Return

VIA

Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

MAM

Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RBC Europe's RBOT Position: Q4 2021 in Review

RBC Europe sold out of Vicarious Surgical (RBOT) in Q4 2021, closing a stake of 7 shares — an estimated $2.99K sold.

RBC Europe first reported a position in RBOT in Q3 2021 and held it in 1 quarter. The position peaked at $2.99K in Q3 2021. 53 funds tracked by Wall St. Rank hold RBOT as of Q4 2021.

RBC Europe reported no remaining Vicarious Surgical position as of Q4 2021 after selling out during the quarter.
RBC Europe sold 7 Vicarious Surgical shares in Q4 2021, an estimated $2.99K.
RBC Europe first reported a position in Vicarious Surgical in Q3 2021 and held it in 1 quarter.
RBC Europe's Vicarious Surgical position peaked at $2.99K in Q3 2021.
53 funds tracked by Wall St. Rank held Vicarious Surgical as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.